John W. Feik
Direktor/Vorstandsmitglied bei StemBioSys, Inc.
Profil
John W.
Feik is the founder of DPT Laboratories Ltd., Feik School of Pharmacy.
He currently holds the position of Director at StemBioSys, Inc., Director at Emtora Biosciences, Inc., and Trustee at Texas Research & Technology Foundation.
Previously, he served as Director at ExThera Medical Corp.
and President & Chief Operating Officer at DFB Pharmaceuticals LLC from 1990 to 2012.
He obtained his undergraduate degree from The University of Texas at Austin.
Aktive Positionen von John W. Feik
Unternehmen | Position | Beginn |
---|---|---|
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Direktor/Vorstandsmitglied | 22.05.2014 |
Texas Research & Technology Foundation
Texas Research & Technology Foundation BiotechnologyHealth Technology Texas Research & Technology Foundation engages in the operation of economic development in the biosciences and technology. It funds and develops innovative ventures and own and operate the Texas Research Park. The company was founded in 1983 and is headquartered in San Antonio, TX. | Direktor/Vorstandsmitglied | - |
Emtora Biosciences, Inc.
Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von John W. Feik
Unternehmen | Position | Ende |
---|---|---|
DFB Pharmaceuticals LLC
DFB Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology DFB Pharmaceuticals LLC develops pharmaceutical products. The company was founded in 1992 and is headquartered in Fort Worth, TX. | Präsident | 01.12.2012 |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Direktor/Vorstandsmitglied | - |
Feik School of Pharmacy | Gründer | - |
DPT Laboratories Ltd.
DPT Laboratories Ltd. Pharmaceuticals: MajorHealth Technology DPT Laboratories Ltd. develops and manufactures pharmaceutical products. It offers full-service outsourcing solutions including pharmaceutical development, site transfers and state-of-the-art pharmaceutical manufacturing, packaging and distribution services. The company was founded by John W. Feik in 1938 and is headquartered in San Antonio, TX. | Gründer | - |
Ausbildung von John W. Feik
The University of Texas at Austin | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 6 |
---|---|
StemBioSys, Inc.
StemBioSys, Inc. BiotechnologyHealth Technology StemBioSys, Inc. develops stem cell technologies. The firm develops technology on the isolation and expansion of specialized adult stem cells for clinical use. Its technology is called XC-marrowECM, which is a patented extracellular matrix laid down by human bone marrow mesenchymal stem cells. The company was founded by Xiao-Dong Chen and Steven A. Davis in 2010 and is headquartered in San Antonio, TX. | Health Technology |
Emtora Biosciences, Inc.
Emtora Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Emtora Biosciences, Inc. operates as a drug development company which focuses on disease treatment and prevention through agents that modulate the mTor pathway in mammals. It produces drugs to slow the aging process and its efficacy in treating age-related diseases. The company was founded in 2012 and is headquartered in San Antonio, TX. | Health Technology |
DPT Laboratories Ltd.
DPT Laboratories Ltd. Pharmaceuticals: MajorHealth Technology DPT Laboratories Ltd. develops and manufactures pharmaceutical products. It offers full-service outsourcing solutions including pharmaceutical development, site transfers and state-of-the-art pharmaceutical manufacturing, packaging and distribution services. The company was founded by John W. Feik in 1938 and is headquartered in San Antonio, TX. | Health Technology |
DFB Pharmaceuticals LLC
DFB Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology DFB Pharmaceuticals LLC develops pharmaceutical products. The company was founded in 1992 and is headquartered in Fort Worth, TX. | Health Technology |
Texas Research & Technology Foundation
Texas Research & Technology Foundation BiotechnologyHealth Technology Texas Research & Technology Foundation engages in the operation of economic development in the biosciences and technology. It funds and develops innovative ventures and own and operate the Texas Research Park. The company was founded in 1983 and is headquartered in San Antonio, TX. | Health Technology |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |